Incyte (INCY) Reports Next Week: Wall Street Expects Earnings Growth

Incyte (INCY) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended June 2024. This widely-known consensus outlook gives a good sense of the company's earnings picture, but how the actual results compare to these estimates is a powerful factor that could impact its near-term stock price. This specialty drugmaker is expected to post quarterly earnings of $1.16 per share in its upcoming report, which represents a year-over-year change of ...